Nathan Dowden

Nathan Dowden

Patrimonio netto: 1 M $ in data 31/08/2026

56 anni
Commercial Services
Consumer Services
Health Technology

Profilo

Nathan J.
Dowden
is President & Chief Operating Officer at Entrada Therapeutics, Inc. since 2024, with employment at Entrada Therapeutics, Inc. starting in 2019.
Former positions include Managing Director at Huron Consulting Group, Inc. from 2014 to 2016; Managing Director at Frankel Group LLC; Senior Consultant at Ernst & Young LLP; Principal at G.D.
Searle & Co., Inc.; Analyst at CIGNA HealthCare, Inc. from 2013 to 2019; and Senior VP-Strategy & Corporate Development at Rubius Therapeutics, Inc. from 2016 to 2019.
Education includes undergraduate studies at the University of Connecticut and an MBA from The University of Chicago Booth School of Business.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
02/09/2026 196.060 ( 0,5% ) 1 M $ 31/08/2026

Posizioni attive di Nathan Dowden

SocietàPosizioneInizio
ENTRADA THERAPEUTICS, INC. Presidente 01/01/2024

Precedenti posizioni note di Nathan Dowden

SocietàPosizioneFine
RUBIUS THERAPEUTICS Corporate Officer/Principal 25/07/2019
Corporate Officer/Principal 01/01/2019
HURON CONSULTING GROUP INC. Corporate Officer/Principal 01/03/2016
Frankel Group LLC
Corporate Officer/Principal -
Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Nathan Dowden

Formazione di Nathan Dowden

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

65

Relazioni di 1° grado

9

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private9

Commercial Services

Commercial Services

Process Industries

Consumer Services

Health Services

Consumer Services

Health Technology

Health Technology

Frankel Group LLC

  1. Mercati
  2. Insiders
  3. Nathan Dowden
ULTIMI ORARI | -40%: I migliori strumenti riservati agli abbonati per identificare i migliori investimenti di domani!
g
:
:
ENTRA ORA